BiomX Inc. Files 8-K on Shareholder Nominations
Ticker: PHGE · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
BiomX Inc. filed an 8-K for shareholder nominations - board shakeup incoming?
AI Summary
BiomX Inc. filed an 8-K on July 30, 2025, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing indicates that BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel, and operates in the biological products sector.
Why It Matters
This filing signals potential changes in BiomX Inc.'s board composition or strategic direction due to shareholder nominations, which could impact the company's future operations and stock performance.
Risk Assessment
Risk Level: medium — Filings related to shareholder nominations can indicate internal disputes or activist investor involvement, which may introduce uncertainty and volatility.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former company name
- July 30, 2025 (date) — Date of report
- Exchange Act Rule 14a-11 (regulation) — Subject of filing
FAQ
What is the specific purpose of the shareholder nominations filed by BiomX Inc.?
The filing states the purpose is "Shareholder Nominations Pursuant to Exchange Act Rule 14a-11."
When was this 8-K filing submitted?
The filing was submitted on July 30, 2025.
What is BiomX Inc.'s primary business sector?
BiomX Inc. operates in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code 2836.
Has BiomX Inc. undergone a name change previously?
Yes, BiomX Inc. was formerly known as Chardan Healthcare Acquisition Corp., with a date of name change on April 30, 2018.
Where is BiomX Inc. headquartered?
BiomX Inc. is headquartered at 22 Einstein St., Floor 4, Ness Ziona, Israel, 7414003.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding BiomX Inc. (PHGE).